J&J, Pfizer and Unitedhealth Among Eaton Vance’s Top Q3 Healthcare Holdings

Wall St. Watchdog reveals information regarding Eaton Vance Management’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 80 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $5.503 billion.

  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Eaton Vance Management reported holding 16,201,040 shares with a market value of $1,077,693,126. This comprised 2.14% of the total portfolio. On 09/30/2011, Eaton Vance Management reported holding 15,330,313 shares with a market value of $976,387,614. This comprised 2.26% of the total portfolio. The net change in shares for this position over the two quarters is -870,727. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Eaton Vance Management reported holding 48,947,283 shares with a market value of $1,008,314,048. This comprised 2% of the total portfolio. On 09/30/2011, Eaton Vance Management reported holding 46,743,703 shares with a market value of $826,428,683. This comprised 1.92% of the total portfolio. The net change in shares for this position over the two quarters is -2,203,580. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Eaton Vance Management reported holding 14,849,676 shares with a market value of $765,946,315. This comprised 1.52% of the total portfolio. On 09/30/2011, Eaton Vance Management reported holding 14,952,469 shares with a market value of $689,607,854. This comprised 1.6% of the total portfolio. The net change in shares for this position over the two quarters is 102,793. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, Eaton Vance Management reported holding 9,545,101 shares with a market value of $556,956,629. This comprised 1.1% of the total portfolio. On 09/30/2011, Eaton Vance Management reported holding 9,323,576 shares with a market value of $512,423,728. This comprised 1.19% of the total portfolio. The net change in shares for this position over the two quarters is -221,525. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Eaton Vance Management reported holding 16,179,653 shares with a market value of $570,979,969. This comprised 1.13% of the total portfolio. On 09/30/2011, Eaton Vance Management reported holding 14,028,094 shares with a market value of $458,718,685. This comprised 1.06% of the total portfolio. The net change in shares for this position over the two quarters is -2,151,559. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Covidien Plc (NYSE:COV): On 06/30/2011, Eaton Vance Management reported holding 8,133,741 shares with a market value of $432,959,030. This comprised 0.86% of the total portfolio. On 09/30/2011, Eaton Vance Management reported holding 7,389,056 shares with a market value of $325,857,358. This comprised 0.76% of the total portfolio. The net change in shares for this position over the two quarters is -744,685. About Company: Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Eaton Vance Management reported holding 4,694,487 shares with a market value of $247,023,901. This comprised 0.49% of the total portfolio. On 09/30/2011, Eaton Vance Management reported holding 4,934,647 shares with a market value of $252,357,845. This comprised 0.59% of the total portfolio. The net change in shares for this position over the two quarters is 240,160. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Thermo Fisher Scientific Inc. (NYSE:TMO): On 06/30/2011, Eaton Vance Management reported holding 3,792,014 shares with a market value of $244,167,779. This comprised 0.48% of the total portfolio. On 09/30/2011, Eaton Vance Management reported holding 3,480,255 shares with a market value of $176,240,111. This comprised 0.41% of the total portfolio. The net change in shares for this position over the two quarters is -311,759. About Company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): On 06/30/2011, Eaton Vance Management reported holding 3,084,649 shares with a market value of $148,741,779. This comprised 0.29% of the total portfolio. On 09/30/2011, Eaton Vance Management reported holding 3,380,502 shares with a market value of $125,822,289. This comprised 0.29% of the total portfolio. The net change in shares for this position over the two quarters is 295,853. About Company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.
  • Humana Inc. (NYSE:HUM): On 06/30/2011, Eaton Vance Management reported holding 309,183 shares with a market value of $24,901,599. This comprised 0.05% of the total portfolio. On 09/30/2011, Eaton Vance Management reported holding 1,598,845 shares with a market value of $116,284,002. This comprised 0.27% of the total portfolio. The net change in shares for this position over the two quarters is 1,289,662. About Company: Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals.

(Note: Data regarding Eaton Vance Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet